Current GFET demand development / LOI planning
A geography for evaluation and demand-development planning. Any long-term testing ambition remains prospective—not a confirmed order, current testing volume or guaranteed forecast.
THE AFRICA COMMERCIALIZATION NETWORK
An ecosystem for
responsible market development.
The network concept connects public institutions, science, capital, commercial execution and assay-development priorities. Country priorities guide planning; they do not establish deployments or endorsements.
FIVE COMPLEMENTARY NETWORKS
Progress requires an entire ecosystem.
01Government & Public Health
Engagement around country needs, public-health priorities and appropriate regulatory coordination.
02Clinical & Scientific
Potential collaboration with hospitals, laboratories, universities and researchers on evidence generation.
03Investment & Capital
Conversations around studies, pilots and future scale; no secured capital is implied.
04Commercial
Country commercialization partners, distributors, service capability and market access.
05Innovation & Assay Development
Africa-informed priorities and target-specific scientific collaboration.
TWO DISTINCT PLANNING CONCEPTS
Nigeria anchors both pathways.
Strategic commercialization / expansion
Nigeria is the anchor market and appears in both groupings. Commercial launch sequencing depends on verified readiness, partners and country requirements.
Planning priority is not deployment, regulatory approval, government endorsement, a signed partnership or a purchase commitment.
Additional longer-term expansion markets may include Cameroon, Uganda, Sierra Leone, Egypt, Morocco, Botswana, Namibia and other African countries. Their inclusion here does not change the separate demand-planning grouping.
PARTNERSHIP-LED ENTRY
Understand. Evaluate. Prepare. Scale.
Country needs
Identify a priority application and buyer, then assess scientific partners and readiness.
Evidence pathway
Map ethics and regulatory requirements and define a measurable pilot.
Implementation pathway
Consider funding, procurement, channel qualification, training and service.
Bring a country perspective.
Describe your institution, territory and proposed contribution to an evidence-led commercialization pathway.